Market Overview:
The global Neostigmine Methylsulfate Injection market is estimated to be valued at US$ 156.75 million in 2023, with a projected compound annual growth rate (CAGR) of 4.5% from 2023 to 2030. Neostigmine Methylsulfate Injection is a medication used primarily for the reversal of neuromuscular blockade induced by muscle relaxants during surgical procedures. It acts by inhibiting the breakdown of acetylcholine, thereby ... Read more

Neostigmine methylsulfate injection is a medication used to treat symptoms of myasthenia gravis. As an acetylcholinesterase inhibitor, it works by increasing acetylcholine levels in the neuromuscular junction. Let's take a deeper look at what this medication is and how it provides relief for those suffering from myasthenia gravis.

What is myasthenia gravis?

Myasthenia gravis is a chronic autoimmune neuromuscular disease that causes weakness in the ... Read more